- Report
- August 2019
- 30 Pages
China
From €1927EUR$2,200USD£1,672GBP
- Report
- December 2022
- 114 Pages
Global
From €3065EUR$3,500USD£2,661GBP
Edema is a medical condition characterized by the accumulation of fluid in the body's tissues. It is a common symptom of many diseases and can be caused by a variety of factors, including trauma, infection, and inflammation. In the biotechnology market, edema is a major area of research and development, with a focus on developing treatments and therapies to reduce the symptoms and improve the quality of life of those affected.
The biotechnology market for edema is highly competitive, with a range of companies developing treatments and therapies to address the condition. These include pharmaceutical companies, biotechnology companies, and medical device companies. Examples of companies in this market include AbbVie, Amgen, AstraZeneca, Biogen, and Novartis. Show Less Read more